Our Helplines
Pregnancy & Breastfeeding Resources
- Morning Sickness
- Drugs in Pregnancy
- Alcohol, Nicotine, Substance Use
- Folic Acid
- Breastfeeding & Drugs
- Cancer in Pregnancy [Forum]
- HIV and HIV Treatment
- Conditions in Pregnancy
- Infectious Diseases in Pregnancy
- Nutrition
- Occupational & Environmental Exposures
- Pharmacokinetics/ Drug Metabolism
- PregTox
- The ReproPsych Group
- CAS Newsletter
Be sure to join us for the 11th Annual Fetal Alcohol Canadian Expertise (FACE) Research Roundtable. Program and registration details.
-
Aug252010
-
Jan112010
-
Dec222009
-
Nov92009
- Read more in our News Archive
Current Studies at Motherisk
-
Oxycodone while Breastfeeding
-
Alcohol Use during Pregnancy
-
Control of Hypertension in Pregnancy Study
-
Folic Acid Before and During Pregnancy
-
Lamisil in Pregnancy
-
Meridia in Pregnancy
-
Nicotine Replacement Therapy During Pregnancy
-
Rheumatoid Arthritis & Arava in Pregnancy
-
Severe Morning Sickness
Anti-convulsants: Phenytoin
Further Reading
-
JAMA 1994 Mar 9; 271(10):767-70.
Scolnik D et al: Neurodevelopment of children exposed in utero to phenytoin and carbamazepine monotherapy. -
American Journal of Medical Genetics.68(1):18-24, 1997 Jan 10.
Nulman I, Scolnik D, Chitayat D, Farkas LD, Koren G: Findings in children exposed in utero to phenytoin and carbamazepine monotherapy: independent effects of epilepsy and medications. -
Teratology, 40: 157-162, 1989.
Koren G, et al: Neuroblastoma after prenatal exposure to phenytoin: Cause and effect? -
Koren G: Neurodevelopment after in utero exposure to phenytoin and carbamazepine. JAMA 272: 850-851, 1994. -
Koren G: In utero exposure to phenytoin or carbamazepine. Can Fam Physicians 41: 1862-1863, 1995.













![Validate my RSS feed [Valid RSS]](/images/rssValid.png)